[Creutzfeld Disease Innovation Award].
D000293:Adolescent; D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use*; D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy / Q000451:nursing*; D001363:Awards and Prizes; D002648:Child; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D006801:Humans; D011437:Propylamines / Q000627:therapeutic use*; D016896:Treatment Outcome
D018759:Adrenergic Uptake Inhibitors; D011437:Propylamines; D000069445:Atomoxetine Hydrochloride